The theme of this conference is "change", which aims to interpret the environment of 20 19 pharmaceutical industry and seek the direction and method of pharmaceutical industry development.
As a representative of industrial enterprises, Liu Yongliang, general manager of Gui Lu Pharmaceutical Marketing, a leading rubber Chinese medicine enterprise, delivered a keynote speech entitled "Looking for another billion blue oceans".
As we all know, at present, gum Chinese medicine is in a turbulent situation.
Overall, the market share of rubber products (Ejiao) is still huge, but the growth rate has slowed down in the past two years. On the one hand, it is difficult to support the increasingly high operation of the terminal, on the other hand, the price of brand Ejiao deviates from the reasonable price range.
Liu Yongliang believes that Ejiao is facing many challenges such as being kicked out of the medical insurance catalogue, chaotic price system and uneven quality, and the rubber market will be reshuffled.
Tortoise shell glue and antler glue, both treasures of traditional medicine, will meet the opportunities of the times and become nourishing upstarts. As far as the pharmaceutical industry in Gui Lu is concerned, the growth rate of 20 18 tortoise plastron glue and antler glue is as high as 69%, showing a strong growth momentum and huge market potential.
In terms of national policies, first, the national macro-policy strongly supports the development of traditional Chinese medicine, and second, tortoise plastron antler glue will be included in the medical insurance catalogue in 2020.
In terms of social development, the middle class is growing, and consumers have great demand for health and nourishment;
The aging population is increasing day by day, and the concept of "disease prevention" is gradually rooted in the hearts of the people. At the same time, people's demand for product efficacy is further refined.
In terms of industry, terminals urgently need potential varieties to improve profit margins and maintain high operating costs.
Of course, the reshuffle of chewing gum Chinese medicine will also be accompanied by the ranking war of chewing gum enterprises.
With the gradual standardization of national macro policies, it will bring opportunities to enterprises that adhere to the quality and brand line, and the market also needs dark horse enterprises with brand, quality, model and after-sales advantages.
As the maker of the industrial standards of tortoise shell glue and antler glue, it is an important participant in the industrial standards of Ejiao. Based on Ejiao, Gui Lu Pharmaceutical Co., Ltd. vigorously develops tortoise plastron glue and antler glue, and always adheres to the road of quality and brand. Ensure the stability of high-quality products and gradually develop into high-quality products.
In order to further meet people's demand for refined functions, Gui Lu Pharmaceutical Co., Ltd. cooperated with authoritative scientific research institutions to reorganize the positioning of three kinds of chewing gum from a scientific point of view. Tortoise shell, colla cornus Cervi and colla Corii Asini are used by the elderly and men and women respectively.
At the same time, Guilu Pharmaceutical made great efforts to create a unique culture of tortoise and deer, set up a professional promotion team of 200 people in the rubber industry, and adopted six promotion measures to help customers turn tortoise shell glue and antler glue into treasures of traditional medicine, benefiting thousands of households together with Ejiao.
This is not only to respond to the call of the country, but also to promote the inheritance, innovation and development of Chinese medicine, and to effectively inherit, develop and utilize the precious wealth left by our ancestors.